scroll to top arrow or icon

{{ subpage.title }}

Drugmakers halve their prices to gain access to China market

January 03, 2021 5:00 AM

WASHINGTON • Drugmakers from AstraZeneca and GlaxoSmithKline to BeiGene have agreed to cut prices on some of their newest drugs in China by an average of 51 per cent in order to be covered by the country's insurance fund.

Chinese maker of Covid-19 vaccine gets $669m shot in the arm

December 08, 2020 5:00 AM

BEIJING • One of China's biggest generic drug makers is investing around US$500 million (S$669 million) to fund research and work on a front runner coronavirus vaccine from Sinovac Biotech that could be weeks away from being administered across the world.

Vaccine expectations must be managed: Dawn

November 12, 2020 12:00 PM

The paper says that relying on an American or Chinese vaccine is impractical, as it may be months before either becomes available in Pakistan.

How a Chinese firm jumped to the front of the coronavirus vaccine race

July 02, 2020 4:28 PM

BEIJING (BLOOMBERG) - When a group of Chinese scientists gathered over barbecue and beer in a Toronto backyard a decade ago, talk drifted to their homeland's vaccines, which had long lagged the developed world on quality and safety. Four of them decided to act.They left top positions at global pharmaceutical companies in Canada to set up a biotechnology firm half a world away in Tianjin, China, hoping to produce vaccines on par with Western countries. Now, that company, CanSino Biologics, is vaulting into the global spotlight as connections on both sides of the Pacific make it one of the front-runners in the race for a coronavirus vaccine.

India working to reduce reliance on Chinese drugs as tensions rise

June 21, 2020 5:00 AM

With border tensions rising, India is trying to reduce its significant dependency on China for pharmaceutical raw materials. The Indian pharmaceutical industry is the third largest in the world by production and 14th by value. Its low-cost and quality generic drug formulations have helped millions with HIV and cancer around the world.

Deadly 'super fungus' Candida auris fuels surge in Chinese drugmakers' shares

April 11, 2019 1:08 PM

HONG KONG (BLOOMBERG) - A deadly fungus that is spreading across the globe is sending Chinese pharma stocks surging.

Subscribe to our free newsletter, GZERO Daily